Skip to main content
CodeRx
Open menu
↑↓ move↵ open CodeRx

C-code: Hospital outpatient (OPPS) codes Hospital outpatient (OPPS) codes

622 codes

Billing context

C-codes are temporary codes for hospital outpatient use under the Medicare Outpatient Prospective Payment System, including pass-through drugs and biologicals (many in C9xxx) and devices. They are generally not reported by physician offices; other payers may not recognize them.
C-codes, page 5 of 7
CodeLong descriptorPayment limit (Q4 2026)AddedStatus
C9147Injection, tremelimumab-actl, 1 mg—Apr 1, 2023Ended Jun 30, 2023
C9148Injection, teclistamab-cqyv, 0.5 mg—Apr 1, 2023Ended Jun 30, 2023
C9149Injection, teplizumab-mzwv, 5 mcg—Apr 1, 2023Ended Jun 30, 2023
C9150Xenon xe-129 hyperpolarized gas, diagnostic, per study dose—Jul 1, 2023Ended Sep 30, 2024
C9151Injection, pegcetacoplan, 1 mg—Jul 1, 2023Ended Sep 30, 2023
C9152Injection, aripiprazole, (abilify asimtufii), 1 mg—Oct 1, 2023Ended Dec 31, 2023
C9153Injection, amisulpride, 1 mg—Oct 1, 2023Ended Dec 31, 2023
C9154Injection, buprenorphine extended-release (brixadi), 1 mg—Oct 1, 2023Ended Dec 31, 2023
C9155Injection, epcoritamab-bysp, 0.16 mg—Oct 1, 2023Ended Dec 31, 2023
C9156Flotufolastat f 18, diagnostic, 1 millicurie—Oct 1, 2023Ended Dec 31, 2023
C9157Injection, tofersen, 1 mg—Oct 1, 2023Ended Dec 31, 2023
C9158Injection, risperidone, (uzedy), 1 mg—Oct 1, 2023Ended Dec 31, 2023
C9159Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activity—Jan 1, 2024Ended Mar 31, 2024
C9160Injection, daxibotulinumtoxina-lanm, 1 unit—Jan 1, 2024Ended Mar 31, 2024
C9161Injection, aflibercept hd, 1 mg—Jan 1, 2024Ended Mar 31, 2024
C9162Injection, avacincaptad pegol, 0.1 mg—Jan 1, 2024Ended Mar 31, 2024
C9163Injection, talquetamab-tgvs, 0.25 mg—Jan 1, 2024Ended Mar 31, 2024
C9164Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)—Jan 1, 2024Ended Mar 31, 2024
C9165Injection, elranatamab-bcmm, 1 mg—Jan 1, 2024Ended Mar 31, 2024
C9166Injection, secukinumab, intravenous, 1 mg—Apr 1, 2024Ended Jun 30, 2024
C9167Injection, adamts13, recombinant-krhn, 10 iu—Apr 1, 2024Ended Jun 30, 2024
C9168Injection, mirikizumab-mrkz, 1 mg—Apr 1, 2024Ended Jun 30, 2024
C9169Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram—Oct 1, 2024Ended Dec 31, 2024
C9170Injection, tarlatamab-dlle, 1 mg—Oct 1, 2024Ended Dec 31, 2024
C9171Injection, pegulicianine, 1 mg—Oct 1, 2024Ended Dec 31, 2024
C9172Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose—Oct 1, 2024Ended Dec 31, 2024
C9173Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram—Jan 1, 2025Ended Jun 30, 2025
C9174Injection, datopotamab deruxtecan-dlnk, 1 mg—Jul 1, 2025Ended Sep 30, 2025
C9175Injection, treosulfan, 50 mg—Jul 1, 2025Ended Sep 30, 2025
C9176Tc-99m from domestically produced non-heu mo-99, [minimum 50 percent], full cost recovery add-on, per study dose—Jan 1, 2026Active
C9248Injection, clevidipine butyrate, 1 mg—Jan 1, 2009Ended Sep 30, 2025
C9250Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml—Jul 1, 2009Active
C9254Injection, lacosamide, 1 mg—Jan 1, 2010Active
C9257Injection, bevacizumab, 0.25 mg—Jan 1, 2010Active
C9275Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose—Jan 1, 2011Ended Dec 31, 2018
C9285Lidocaine 70 mg/tetracaine 70 mg, per patch—Jul 1, 2011Active
C9290Injection, bupivacaine liposome, 1 mg—Apr 1, 2012Ended Dec 31, 2024
C9293Injection, glucarpidase, 10 units—Oct 1, 2012Active
C9300Injection, indigotindisulfonate sodium, 1 mg—Apr 1, 2025Ended Jun 30, 2025
C9301Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose—Apr 1, 2025Ended Jun 30, 2025
C9302Injection, zanidatamab-hrii, 2 mg—Apr 1, 2025Ended Jun 30, 2025
C9303Injection, zolbetuximab-clzb, 1 mg—Apr 1, 2025Ended Jun 30, 2025
C9304Injection, marstacimab-hncq, 0.5 mg—Apr 1, 2025Ended Jun 30, 2025
C9305Injection, nipocalimab-aahu, 3 mg—Oct 1, 2025Ended Dec 31, 2025
C9306Injection, telisotuzumab vedotin-tllv, 1 mg—Oct 1, 2025Ended Dec 31, 2025
C9307Injection, linvoseltamab-gcpt, 1 mg—Jan 1, 2026Ended Mar 31, 2026
C9308Injection, carboplatin (avyxa), 1 mg—Jan 1, 2026Ended Mar 31, 2026
C9309Injection, onasemnogene abeparvovec-brve, per treatment—Apr 1, 2026Ended Jun 30, 2026
C9310Injection, leucovorin calcium (avyxa), 1 mg—Jul 1, 2026Ended Sep 30, 2026
C9311Injection, eplontersen, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)—Oct 1, 2026Active
C9312Injection, trabectedin (apotex), not therapeutically equivalent to j9362, 0.01 mg—Oct 1, 2026Active
C9313Injection, pivekimab sunirine-pvzy, 0.01 mg—Oct 1, 2026Active
C9349Puraply, and puraply antimicrobial, any type, per square centimeter—Jan 1, 2015Ended Dec 31, 2016
C9352Microporous collagen implantable tube (neuragen nerve guide), per centimeter length—Jan 1, 2008Active
C9353Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter length—Jan 1, 2008Active
C9354Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter—Jan 1, 2008Active
C9355Collagen nerve cuff (neuromatrix), per 0.5 centimeter length—Jan 1, 2008Active
C9356Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter—Jul 1, 2008Active
C9358Dermal substitute, native, non-denatured collagen, fetal bovine origin (surgimend collagen matrix), per 0.5 square centimeters—Jul 1, 2008Active
C9359Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per 0.5 cc—Oct 1, 2008Active
C9360Dermal substitute, native, non-denatured collagen, neonatal bovine origin (surgimend collagen matrix), per 0.5 square centimeters—Jul 1, 2009Active
C9361Collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter length—Jul 1, 2009Active
C9362Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold strip), per 0.5 cc—Jul 1, 2009Active
C9363Skin substitute, integra meshed bilayer wound matrix, per square centimeter—Jul 1, 2009Active
C9364Porcine implant, permacol, per square centimeter—Jul 1, 2009Active
C9399Unclassified drugs or biologicalsNOC / NOS—Jan 1, 2004Active
C9407Iodine i-131 iobenguane, diagnostic, 1 millicurie—Jan 1, 2019Ended Dec 31, 2019
C9408Iodine i-131 iobenguane, therapeutic, 1 millicurie—Jan 1, 2019Ended Dec 31, 2019
C9441Injection, ferric carboxymaltose, 1 mg—Jan 1, 2014Ended Jun 30, 2014
C9442Injection, belinostat, 10 mg—Jan 1, 2015Ended Dec 31, 2015
C9443Injection, dalbavancin, 10 mg—Jan 1, 2015Ended Dec 31, 2015
C9444Injection, oritavancin, 10 mg—Jan 1, 2015Ended Dec 31, 2015
C9445Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 units—Apr 1, 2015Ended Dec 31, 2015
C9446Injection, tedizolid phosphate, 1 mg—Jan 1, 2015Ended Dec 31, 2015
C9447Injection, phenylephrine and ketorolac, 4 ml vial—Jan 1, 2015Ended Sep 30, 2019
C9448Netupitant 300 mg and palonosetron 0.5 mg, oral—Apr 1, 2015Ended Jun 30, 2015
C9449Injection, blinatumomab, 1 mcg—Apr 1, 2015Ended Dec 31, 2015
C9450Injection, fluocinolone acetonide intravitreal implant, 0.01 mg—Apr 1, 2015Ended Dec 31, 2015
C9451Injection, peramivir, 1 mg—Apr 1, 2015Ended Dec 31, 2015
C9452Injection, ceftolozane 50 mg and tazobactam 25 mg—Apr 1, 2015Ended Dec 31, 2015
C9453Injection, nivolumab, 1 mg—Jul 1, 2015Ended Dec 31, 2015
C9454Injection, pasireotide long acting, 1 mg—Jul 1, 2015Ended Dec 31, 2015
C9455Injection, siltuximab, 10 mg—Jul 1, 2015Ended Dec 31, 2015
C9456Injection, isavuconazonium sulfate, 1 mg—Oct 1, 2015Ended Dec 31, 2015
C9457Injection, sulfur hexafluoride lipid microsphere, per ml—Oct 1, 2015Ended Dec 31, 2015
C9458Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries—Jan 1, 2016Ended Jun 30, 2016
C9459Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries—Jan 1, 2016Ended Jun 30, 2016
C9460Injection, cangrelor, 1 mg—Jan 1, 2016Active
C9461Choline c 11, diagnostic, per study dose—Apr 1, 2016Ended Dec 31, 2016
C9462Injection, delafloxacin, 1 mg—Apr 1, 2018Ended Sep 30, 2026
C9463Injection, aprepitant, 1 mg—Apr 1, 2018Ended Dec 31, 2018
C9464Injection, rolapitant, 0.5 mg—Apr 1, 2018Ended Dec 31, 2018
C9465Hyaluronan or derivative, durolane, for intra-articular injection, per dose—Apr 1, 2018Ended Dec 31, 2018
C9466Injection, benralizumab, 1 mg—Apr 1, 2018Ended Dec 31, 2018
C9467Injection, rituximab and hyaluronidase, 10 mg—Apr 1, 2018Ended Dec 31, 2018
C9468Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u.—Apr 1, 2018Ended Dec 31, 2018
C9469Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg—Apr 1, 2018Ended Jun 30, 2018
C9470Injection, aripiprazole lauroxil, 1 mg—Apr 1, 2016Ended Dec 31, 2016
C9471Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg—Apr 1, 2016Ended Dec 31, 2016
C9472Injection, talimogene laherparepvec, 1 million plaque forming units (pfu)—Apr 1, 2016Ended Dec 31, 2016